HomeCCCC • NASDAQ
C4 Therapeutics Inc
add
$3.32
1.78%
After Hours:(0.60%)-0.020
$3.30
Closed: Sep 18, 5:40:03 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.46M | -46.17% |
Operating expense | 8.77M | -9.57% |
Net income | -26.02M | -46.87% |
Net profit margin | -402.60 | -172.84% |
Earnings per share | -0.37 | -42.31% |
EBITDA | -27.89M | -32.83% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 214.55M | -18.76% |
Total assets | 296.53M | -22.19% |
Total liabilities | 122.46M | -8.63% |
Total equity | 174.06M | — |
Shares outstanding | 71.17M | — |
Price to book | 1.38 | — |
Return on assets | -23.13% | — |
Return on capital | -28.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.02M | -46.87% |
Cash from operations | -12.06M | -142.40% |
Cash from investing | 38.92M | 432.49% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 26.86M | 262.37% |
Free cash flow | -1.63M | -194.18% |
Previous close
$3.38
Day range
$3.27 - $3.58
Year range
$1.09 - $7.14
Market cap
236.29M USD
Avg Volume
1.69M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
110
